Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 8/20 | 0.44 |
| ▸ | ALOX5AP | P20292 | 2/20 | 0.35 |
| ▸ | FEN1 | P39748 | 2/20 | 0.35 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.33 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.33 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.32 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.32 |
| ▸ | ACP1 | P24666 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25445903 | 0.94 | PDK2 (0.38) | PDK2ALOX5APFEN1MCL1MAP4K4 | |
| SCHEMBL25445453 | 0.92 | MAP4K4 (0.38) | PDK2MCL1MAP4K4 | |
| SCHEMBL25444650 | 0.90 | MCL1 (0.38) | PDK2ALOX5APFEN1MCL1MAP4K4 | |
| SCHEMBL25445532 | 0.90 | MCL1 (0.38) | PDK2ALOX5APFEN1MCL1MAP4K4 | |
| SCHEMBL14515088 | 0.86 | PDK2 (0.41) | PDK2 | |
| SCHEMBL25444705 | 0.86 | PDK2 (0.41) | PDK2 | |
| SCHEMBL25445501 | 0.85 | MCL1 (0.35) | PDK2MCL1MAP4K4 | |
| SCHEMBL25445553 | 0.85 | PDK2 (0.35) | PDK2ALOX5APFEN1MCL1MAP4K4 | |
| SCHEMBL25445887 | 0.85 | PDK2 (0.40) | PDK2 | |
| SCHEMBL13376508 | 0.84 | PDK2 (0.50) | PDK2MCL1MAP4K4KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230143779-A1 | ORGANIC SOLID-STATE LASER, COMPOUND AND USE THEREOF | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2023-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230143779-A1 | ORGANIC SOLID-STATE LASER, COMPOUND AND USE THEREOF | LEF1, CCNT1, CCNT2 | PDK2 3407/4885ALOX5AP 1080/4885FEN1 745/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.